ChemFaces have 29 compounds are similar structure. Ginsenoside Compound K (CAS#39262-14-1); Ginsenoside MC (CAS#175484-06-7); Gynosaponin I (CAS#1207861-69-5); Gynosaponin TN2 (CAS#77658-95-8); Ginsenoside F2 (CAS#62025-49-4); Ginsenoside Rd2 (Quinquenoside L10) (CAS#83480-64-2); Gypenoside XVII (CAS#80321-69-3); Notoginsenoside L13 (CAS#2485859-56-9); Ginsenoside Rb2 (CAS#11021-13-9); Ginsenoside Rb3 (CAS#68406-26-8); Notoginsenoside Fc (CAS#88122-52-5); Ginsenoside Rb1 (CAS#41753-43-9); Notoginsenoside Fa (CAS#88100-04-3); Notoginsenoside R4 (CAS#87741-77-3); Ginsenoside Ra2 (CAS#83459-42-1); Notoginsenoside Fe (CAS#88105-29-7); Ginsenoside Rc (CAS#11021-14-0); Ginsenoside F1 (CAS#53963-43-2); 3-Acetyl-ginsenoside F1 (CAS#1881225-08-6); Ginsenoside F3 (CAS#62025-50-7); Ginsenoside F5 (CAS#189513-26-6); Ginsenoside Rg1 (CAS#22427-39-0); Notoginsenoside R1 (CAS#80418-24-2); Ginsenoside Re (CAS#52286-59-6); Ginsenoside Rd (CAS#52705-93-8); Notoginsenoside E (CAS#193976-50-0); Gypenoside XLVI (CAS#94705-70-1); Ginsenoside F4 (CAS#181225-33-2); Quasipanaxatriol (CAS#171903-78-9).
Those compounds are series compounds, which having the similar structure but only some different in the individual atoms, functional groups and substructures. Maybe they also have the different physicochemical property, bioactivity and pharmacological property. In the drug design and reserach, they play an important role of improving the success rate of drug screening, researching of drug toxicity and acquiring of other data.
